Triple Therapy Prevention of Recurrent Intracerebral Disease Events Trial: Rationale, design and progress

Article

Abstract: Background: Patients who suffer intracerebral hemorrhage (ICH) are at very high risk of recurrent IC

Palabras claves:

Blood pressure lowering, Clinical trial, Hypertension, Intracerebral Hemorrhage, Outcomes

Autores:

Anderson C.S., Arima H., Billot L., Chalmers J., Chen C., Chow C.K., De Silva H.A., Fisher U., Freed R., Kherkheulidze T., Klijn C.J.M., Lee T.H., Lindley R.I., MacMahon S., Martins S.O., Naismith S., Octavio Marques Pontes-Neto, Robinson T.G., Rodgers A., Salman R.A.S., Schreuder F.H., Senanayake B., Song L., Thang N.H., Wahab K.W., Wang J.G., Woodward M., Zaidi W.A.W.

Fuentes:

scopus